Home / Stock ratings / HSIC
Stock rating · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Henry Schein Inc (HSIC) Stock Rating & Analysis
As of October 13, 2026, MELANY rates Henry Schein Inc 63 out of 100 (Hold). Its highest factor score is catalyst setup at 91, and its lowest is business quality at 40.
MELANY ratingRated 2026-10-13HSIC · composite score
About Henry Schein Inc
Henry Schein Inc is a solutions company for healthcare professionals, providing healthcare equipment, products, and services to office-based dental and medical practitioners as well as alternative sites of care. Its reportable segments are Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology.
Rating as of 2026-10-13 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why HSIC scores 63/100
HSIC's 8 factor scores run from 40 to 91, and 3 of them sit above its composite of 63. Here is how HSIC breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 14.2x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Earnings in 21 days (strong beat history)
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
- Earnings in 21 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for HSIC
- No specific company-level red flags detected, monitor macro regime changes
Sector and theme context
Henry Schein Inc sits in the Healthcare sector theme, which MELANY currently rates 62/100 for strength. Theme strength feeds HSIC's momentum and catalyst factors above.
Tracking HSIC
Henry Schein Inc rates Hold right now, so MELANY is not flagging a fresh entry. Add HSIC to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.
How MELANY rates HSIC
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Henry Schein Inc's 63/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about HSIC
Is Henry Schein Inc (HSIC) a buy?
As of 2026-10-13, MELANY rated Henry Schein Inc Hold with a composite score of 63/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Henry Schein Inc's MELANY score?
Henry Schein Inc (HSIC) has a MELANY composite score of 63/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the HSIC stock rating calculated?
MELANY scores HSIC from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Henry Schein Inc stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Henry Schein Inc (HSIC) Hold with a composite of 63/100 as of 2026-10-13. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the HSIC stock price forecast?
MELANY does not publish price targets or forecasts for HSIC. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 63/100 across eight factors for Henry Schein Inc, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is HSIC stock overvalued or undervalued?
MELANY's valuation factor currently reads 63/100 for Henry Schein Inc, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives HSIC's read.
What price should I buy HSIC at?
MELANY is not flagging a fresh entry for HSIC at its current Hold rating, so there is no entry zone to publish right now. Add HSIC to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.
What are the risks of buying HSIC stock?
The top risks MELANY currently flags for Henry Schein Inc: No specific company-level red flags detected, monitor macro regime changes. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Henry Schein Inc a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 40/100 for Henry Schein Inc, and earnings track record, at 76/100. The 63/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will HSIC stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 60/100 for HSIC right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this HSIC rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-13. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores HSIC continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, HSIC included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.